As of 2025-10-16, the EV/EBITDA ratio of Biosynex SA (ALBIO.PA) is -3.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALBIO.PA's latest enterprise value is 70.63 mil EUR. ALBIO.PA's TTM EBITDA according to its financial statements is -18.56 mil EUR. Dividing these 2 quantities gives us the above ALBIO.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 4.4x | 4.3x |
| Forward P/E multiples | 6.0x - 11.5x | 8.8x |
| Fair Price | (8.98) - (7.45) | (9.54) |
| Upside | -1405.2% - -1183.6% | -1486.5% |
| Date | EV/EBITDA |
| 2025-10-15 | -3.80 |
| 2025-10-14 | -3.80 |
| 2025-10-13 | -3.79 |
| 2025-10-10 | -3.80 |
| 2025-10-09 | -3.79 |
| 2025-10-08 | -3.82 |
| 2025-10-07 | -3.82 |
| 2025-10-06 | -3.77 |
| 2025-10-03 | -3.79 |
| 2025-10-02 | -3.80 |
| 2025-10-01 | -3.81 |
| 2025-09-30 | -3.81 |
| 2025-09-29 | -3.80 |
| 2025-09-26 | -3.73 |
| 2025-09-25 | -4.33 |
| 2025-09-24 | -4.32 |
| 2025-09-23 | -4.32 |
| 2025-09-22 | -4.31 |
| 2025-09-19 | -4.30 |
| 2025-09-18 | -4.32 |
| 2025-09-17 | -4.32 |
| 2025-09-16 | -4.32 |
| 2025-09-15 | -4.35 |
| 2025-09-12 | -4.33 |
| 2025-09-11 | -4.34 |
| 2025-09-10 | -4.31 |
| 2025-09-09 | -4.30 |
| 2025-09-08 | -4.30 |
| 2025-09-05 | -4.31 |
| 2025-09-04 | -4.31 |
| 2025-09-03 | -4.29 |
| 2025-09-02 | -4.29 |
| 2025-09-01 | -4.29 |
| 2025-08-29 | -4.30 |
| 2025-08-28 | -4.30 |
| 2025-08-27 | -4.31 |
| 2025-08-26 | -4.31 |
| 2025-08-25 | -4.30 |
| 2025-08-22 | -4.32 |
| 2025-08-21 | -4.31 |
| 2025-08-20 | -4.31 |
| 2025-08-19 | -4.31 |
| 2025-08-18 | -4.31 |
| 2025-08-15 | -4.32 |
| 2025-08-14 | -4.30 |
| 2025-08-13 | -4.31 |
| 2025-08-12 | -4.31 |
| 2025-08-11 | -4.32 |
| 2025-08-08 | -4.34 |
| 2025-08-07 | -4.34 |